Alzheimer’s disease can be characterized by three main phases:
(1) Preclinical AD: Abnormal AD biomarkers but no clinical symptoms
(2) MCI (Mild Cognitive Impairment): Individuals are mildly symptomatic but do not have dementia. MCI denotes cognitive decline without impairment in activities of daily living
(3) Dementia: Individuals show progressive loss of cognitive function and the ability to live independently
Read more about the typical course of Alzheimer’s disease
Related content
This article discusses potential next steps for enhancing clinical trial outcomes in neurodegenerative diseases, with the ultimate goal of improving patient care
Professor Dr. Matthew Kiernan discusses the limitations of current trial models.
Professor Dr. Matthew Kiernan discusses the limitations of current trial models.